Current management and future directions in metastatic pancreatic adenocarcinoma

Of the anticipated 50,000 individuals expected to be diagnosed with pancreatic cancer in 2016, the majority will have metastatic disease. Given the noncurative nature of advanced pancreatic adenocarcinoma, treatment is aimed at inducing disease regression, controlling symptom, and extending life. Th...

Full description

Bibliographic Details

Published in:	Cancer Vol. 122; no. 24; pp. 3765 - 3775
Main Authors:	Varghese, Anna M., Lowery, Maeve A., Yu, Kenneth H., O'Reilly, Eileen M.
Format:	Journal Article
Language:	English
Published:	United States 15.12.2016
Subjects:	Adenocarcinoma - drug therapy Animals Antineoplastic Combined Chemotherapy Protocols - therapeutic use chemotherapy Humans metastatic pancreatic cancer Pancreatic Neoplasms - drug therapy targets treatment standards pancreatic cancer treatment standards metastatic chemotherapy targets
ISSN:	0008-543X, 1097-0142
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!